News
Global Cannabis News & Analysis | Business of Cannabis
News · page 50
- Data & Analysis
What Is The Canpain Study And Will It Help Bring CBMPs Onto The NHS?
THE UK’s Health Research Authority (HRA) has approved the country’s first clinical study using cannabis flower for the treatment of chronic pain.
- News
Worlds Largest THC Toxicological Study Shows ‘Very Positive’ Signs So Far
SINCE 2020’s controversial Kanavape case, the European hemp industry has continued to develop at a rapid pace.
- Pharmaceutical
OCT’s 8 Board Members Survive Vote To Oust Them As CEO Denounces ‘Scaremongering’
Oxford Cannabinoid Technologies’ (OCT) shareholders have voted to keep all eight of its current directors, following calls from its co-founder to oust them.
- Markets & Stocks
EU Cannabis Stocks Review: SEED Innovations Eurox Investment Bears Fruit, Akanda Continues To Climb & Intercure Posts Record Figures
Despite a number of positive announcements coming from the UK this week, British cannabis stocks failed to match the dramatic upswings experienced by their US counterparts.
- CBD Market
European Round-Up: 5,000 UK Patients To Receive Cannabis In Ground-Breaking Trial, TV Station Invests In Cannabis, Tobacco Firm’s Cannabis Ambition, Swiss CBD Setback
A FIRST for the UK this week with the announcement that a major study into the potential benefits of cannabis for pain relief is to be launched.
- Adult-Use
As North American Investment In EU Cannabis Industry Tops $600m, Companies Are Gearing Up For The ‘Next Wave’ Of Capital Influx
Read our latest interview with Casa Verde’s Managing Partner, Karan Wadhera, about the opportunities Europe presents for overseas investors.
- Policy & Regulation
London Drug Diversion Pilot Victim Of Misinformation And ‘Backwards, Stigmatising Attitude Towards Cannabis’
IN JANUARY, news that London Mayor Sadiq Khan was planning on launching a drug diversion pilot scheme in the capital met with widespread condemnation from MPs and the media alike, with prominent voices warning it would ‘effectively decriminalise cannabis’.
- News
Love Hemp Shareholders Vote Against Ousting Chairman & Slashing Marketing Spend As It Reports 30% Drop In Revenues
LOVE Hemp’s shareholders have overwhelmingly voted against ousting the company’s Chairman Andrew Male, slashing the boards’ remuneration and halting all marketing spend.
- CBD Market
CBD Industry Welcomes FSA’s Public List As ‘Milestone Moment’ Bringing Much Needed ‘Clarity’ To Sector – But Questions Remain Over Its Handling Of The Process
LAST week saw the highly anticipated publication of the Food Standards Agency’s (FSA) Public List, including 3536 CBD products which will now legally be allowed to remain on sale in the UK.
- Adult-Use
Over 340,000 Patients In Europe Set To Benefit From Medical Cannabis Access In 2022
NEW sales forecasts for the medical cannabis market in Europe predict that €353 million-worth of medical cannabis will be sold on the continent in 2022, rising to €2.3 billion by 2026 – a potential 544% increase over the forecast period.
- CBD Market
European Round-Up: Germany’s Decriminalisation Delay ‘Incomprehensible’, Maltese Doctor Charged With Drug Trafficking, $100m UK Cannabis Investment et al…
DESPITE being one of the key policies of the ‘Traffic-Light’ German Government do not expect cannabis legalisation to be enacted quickly, says the Minister responsible for its implementation.
- CBD Market
One Year Late The FSA Publishes List Of Eligible UK CBD Products – For Now
AFTER a delay of exactly one year the long-awaited Public List of validated UK CBD products has been published by the Food Standards Agency.
